EU Council adopts new pharma package to modernize drug legislation
The Council of the European Union has approved a comprehensive "pharma package" of rules aimed at updating the regulatory framework for medicines across the bloc.
The new legislation seeks to streamline approval processes, strengthen supply chain resilience and improve patient access to treatments throughout member states.
At the same time, the U.S. Department of Health and Human Services announced the ARPA-H SURPASS program, a funding effort to develop a real-time adaptive trial platform intended to speed clinical development and bring products to market faster.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Euro Roundup: Council of the EU adopts ‘pharma package’ to advance legislative reform agenda”
read at raps ↗
comments(0)
5-min edit window · permanent after that